PROCESS FOR THE PREPARATION OF NLRP3 INHIBITORS
The present invention relates to intermediates and processes useful for preparing 1-ethyl-N-((1,2,3,5,6,7-hexahydro-s-indacen-4-yl)carbamo yl)piperidine-4-sulfonamide and salts thereof. The present invention further relates to 1-ethyl-N-((1,2,3,5,6,7- hexahydro-s-indacen-4-yl)carbamoyl)piperidine-4-...
Saved in:
Main Authors | , , , , , |
---|---|
Format | Patent |
Language | English Spanish |
Published |
29.04.2024
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The present invention relates to intermediates and processes useful for preparing 1-ethyl-N-((1,2,3,5,6,7-hexahydro-s-indacen-4-yl)carbamo yl)piperidine-4-sulfonamide and salts thereof. The present invention further relates to 1-ethyl-N-((1,2,3,5,6,7- hexahydro-s-indacen-4-yl)carbamoyl)piperidine-4-sulfonamide and salts thereof when prepared by such processes and to associated pharmaceutical compositions and uses for the treatment and prevention of medical disorders and diseases, most especially by NLRP3 inhibition.
La presente invención se refiere a intermediarios y procesos útiles para preparar 1-etil-N-((1,2,3,5,6,7-hexahidro-s-indacen-4- il)carbamoil)piperidin-4-sulfonamida y sales de la misma. La presente invención se refiere además a 1-etil-N-((1,2,3,5,6,7-hexa hidro-s-indacen-4-il)carbamoil)piperidin-4-sulfonamida y sales de la misma cuando se prepara mediante tales procesos y a composiciones farmacéuticas asociadas y usos para el tratamiento y prevención de trastornos médicos y enfermedades, más especialmente, mediante inhibición de NLRP3. |
---|---|
Bibliography: | Application Number: MX20230014547 |